ADALIMUMAB (ADL) - ANVISA Registration 10350840428

Access comprehensive regulatory information for ADALIMUMAB (ADL) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10350840428 and manufactured by BODITECH MED INC.. The registration is held by BIOSYS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 3 companies making the same product including BUHLMANN LABORATORIES AG, PROGENIKA BIOPHARMA S.A., and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.